2025 American Society of Clinical Oncology Annual Meeting | Stanford Cancer Institute

2025 American Society of Clinical Oncology Annual Meeting

Stanford is honored to have presenters from diverse disciplines and areas of expertise at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting. Below is a list of oral abstract, panel, and symposium speakers. Stanford's numerous poster presentations can be found on the ASCO website.

Saurabh Dahiya, MD, FACP

A phase 1 study of KITE-363 anti-CD19/CD20 chimeric antigen receptor (CAR) T-cell therapy in patients (pts) with relapsed/refractory (R/R) B-cell lymphoma (BCL)

Maximilian Diehn, MD, PhD

Assay showdown: Comparing cutting-edge blood tests for cancer detection

Pauline Funchain, MD

irAEs and autoimmune disease: What to do when checkpoint blockade is contraindicated

Iris Gibbs, MD, FACR, FASTRO

Radiation for multiple central nervous system metastases: Is less more?

Lipika Goyal, MD

Emerging treatment paradigms in bile duct cancer

Saad Khan, MD

Medical oncologist perspective

Allison Kurian, MD, MSc

Association of an ancestry-specific variant near the ESR1 gene with cancer risk and breast density in women of self-reported Hispanic ancestry

Quynh-Thu Le, MD, FACR, FASTRO

Sniffing victory: Further breakthroughs in nasopharyngeal cancer

Manali Patel, MD

Improving care of older adults with cancer: A randomized trial

Susan Swetter, MD

Artificial intelligence for melanoma early detection and improving health equity

Melinda Telli, MD

New agents for triple-negative breast cancer

Reena Thomas, MD, PhD

A phase 1 study of B7H3 CAR-T cells administered intracranially in recurrent glioblastoma

Heather Wakelee, MD

ctDNA and liquid biopsies for early and advanced lung cancer